Tech Company Financing Transactions
PathoGn Funding Round
Illumina Accelerator Program participated in a Seed capital raise for PathoGn. The funding round was announced by the company on 8/5/2015.
Transaction Overview
Company Name
Announced On
8/5/2015
Transaction Type
Accelerator
Amount
Unknown
Round
Seed
Investors
Proceeds Purpose
The company will use the proceeds to accelerate its initial development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
PathoGn is a San Francisco, CA-based company that uses genomics and machine learning to create pathogen diagnostics and disease forecasting products that can be used in agriculture.
Management Team
Browse more venture capital transactions:
Prev: 8/5/2015: Mevion Medical Systems venture capital transaction
Next: 8/5/2015: Metacrine venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs